280 results
Page 3 of 14
6-K
EX-99.1
fujpww w0
1 Aug 22
Current report (foreign)
4:48pm
D
frq5aok0zs h7
29 Jul 22
$34.64M in equity, sold $34.64M, 4 investors
6:15pm
6-K
EX-99.1
tjdglu1q
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-2.1
o37zwqmhd7nun2
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-10.4
9a0qs3
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-10.3
jkekury9xngf 47dnw9e
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-2.1
gx8vp8zl
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-99.1
yxusfkzwoeiv3f3qf
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
6-K
EX-99.1
oyhjpsy
23 Jun 22
Territory of the British Virgin Islands
4:05pm
6-K
EX-99.1
e5tv573
31 Mar 22
Portage Biotech Provides Update on Clinical-Stage and Development Programs
8:00am
20-F/A
9h9g9f
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.2
uq2la75
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.1
j7j7voz
25 Feb 22
Current report (foreign)
5:29pm